Technology Profits Confidential editor, Ray Blanco shares a profitable tech opportunity at a great price. “If you want a piece of the EV market, your best bet may not be to buy the car company with the most attractive vehicle. You want to look at companies that are working on the battery tech that will power the future of the auto market. ”
Trend Trader Daily editor, Lou Basenese makes a bold - and accurate - call. “The reason I can be so emphatic in my beliefs is simple: I recognize that changes in consensus happen slowly — even when the evidence is hiding in plain sight.”
Trend Trader Daily editor, Lou Basenese shares a handful of charts that put recent investment news into perspective. “The recent market sell-off is healthy. It’s a prime opportunity to add to positions you love at cheaper prices.”
Green Zone Fortunes editor, Charles Sizemore shares the pros - and the cons - of the buy and hold. “In the real world, stock returns do not follow a straight line — they vary wildly over years or even decades. If there is a timing mismatch, for example, if your retirement’s early years correspond to a bear market, you can have a real problem.”
Trend Trader Daily editor, Lou Basenese shares how he personally times his tech investments. “Determining whether a technology or service will ever make it into the mainstream comes down to answering a basic but vital question…”
Great Stuff editor, Joseph Hargett explains why AMC is now poised to actually win big post-pandemic. “The company will survive, and it will come out of the pandemic leaner and better capitalized than when it went in.”
If you think the GameStop Corp. (GME) saga only involves a small handful of heavily-shorted stocks, think again… Pretty much every heavily-shorted stock in the Russell 3000 with a nose-bleed valuation is surging. But that does NOT mean a GME endorsement. So, where SHOULD you be investing? Glad you asked…
With shares of Novavax, Inc. (NVAX) doubling during the last few weeks of January — and surging more than 3,000% over the last year — investors are on the lookout for the next Covid-19 vaccine stock set to soar. But it’s no easy task. There are currently 4,636 Covid-19 treatments and trials underway. Sorting through all those trials quickly enough to identify any actionable opportunities might seem like mission impossible. But, Trend Trader Daily editor and founder, Lou Basenese, is going to help you do exactly that.
Trend Trader Daily editor and founder, Lou Basenese, is back with his prediction on 2021’s top performer: biotech. “It’s now become vital to survival. Literally. And that’s not going to change anytime soon.” Read on to find out why, and how you can get in on the Biotech Boom 2.0.